Pietro Genovese

4.7k total citations · 2 hit papers
35 papers, 3.0k citations indexed

About

Pietro Genovese is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Pietro Genovese has authored 35 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Genetics and 18 papers in Oncology. Recurrent topics in Pietro Genovese's work include CRISPR and Genetic Engineering (23 papers), Virus-based gene therapy research (19 papers) and CAR-T cell therapy research (17 papers). Pietro Genovese is often cited by papers focused on CRISPR and Genetic Engineering (23 papers), Virus-based gene therapy research (19 papers) and CAR-T cell therapy research (17 papers). Pietro Genovese collaborates with scholars based in United States, Italy and Germany. Pietro Genovese's co-authors include Luigi Naldini, Michael C. Holmes, Angelo Lombardo, Philip D. Gregory, Chiara Bonini, Dale Ando, Christian Beauséjour, Giulia Schiroli, Fyodor D. Urnov and Cesare Galli and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Pietro Genovese

34 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

2007 647 citations Angelo Lombardo, Pietro Genovese et al. Nature Biotechnology profile →
Targeted genome editing in human repopulating haematopoietic stem cells

2014 434 citations Pietro Genovese, Giulia Schiroli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pietro Genovese United States	16	2.4k	1.4k	853	366	201	35	3.0k
Ayal Hendel Israel	22	2.6k 1.1×	782 0.5×	405 0.5×	185 0.5×	88 0.4×	37	2.8k
Cynthia C. Bartholomae Germany	20	2.5k 1.0×	2.0k 1.4×	673 0.8×	221 0.6×	80 0.4×	33	3.0k
Roger P. Hollis United States	27	1.7k 0.7×	1.1k 0.8×	425 0.5×	249 0.7×	98 0.5×	58	2.2k
Mara Pavel-Dinu United States	9	1.9k 0.8×	766 0.5×	362 0.4×	141 0.4×	88 0.4×	16	2.1k
Joab Camarena United States	11	2.1k 0.9×	807 0.6×	328 0.4×	104 0.3×	105 0.5×	16	2.3k
Ali Nowrouzi Germany	19	1.5k 0.6×	999 0.7×	550 0.6×	183 0.5×	69 0.3×	28	2.0k
Andrea Calabria Italy	17	1.1k 0.5×	736 0.5×	400 0.5×	233 0.6×	138 0.7×	35	1.6k
Samuel L. Murphy United States	13	1.5k 0.6×	1.2k 0.9×	528 0.6×	177 0.5×	152 0.8×	27	2.0k
Jennifer E. Adair United States	26	1.3k 0.5×	683 0.5×	568 0.7×	314 0.9×	220 1.1×	64	1.9k
Jonathan D. Finn United States	18	1.2k 0.5×	1.2k 0.8×	630 0.7×	153 0.4×	396 2.0×	36	1.8k

Countries citing papers authored by Pietro Genovese

Since Specialization

Citations

This map shows the geographic impact of Pietro Genovese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Genovese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Genovese more than expected).

Fields of papers citing papers by Pietro Genovese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Genovese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Genovese. The network helps show where Pietro Genovese may publish in the future.

Co-authorship network of co-authors of Pietro Genovese

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Genovese. A scholar is included among the top collaborators of Pietro Genovese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Genovese. Pietro Genovese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klatt, Denise, Lucia Piceni Sereni, Boya Liu, et al.. (2024). Engineered packaging cell line for the enhanced production of baboon-enveloped retroviral vectors. Molecular Therapy — Nucleic Acids. 35(4). 102389–102389. 2 indexed citations

Landoni, Elisa, Mark G. Woodcock, Gabriel A. Barragán, et al.. (2024). IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity. Nature Communications. 15(1). 89–89. 30 indexed citations

Montepeloso, Annita, Davide Mattioli, Danilo Pellin, et al.. (2024). Haploinsufficiency at the CX3CR1 locus of hematopoietic stem cells favors the appearance of microglia-like cells in the central nervous system of transplant recipients. Nature Communications. 15(1). 10192–10192.

Levesque, Sébastien, Andrea Cosentino, Archana Verma, Pietro Genovese, & Daniel E. Bauer. (2024). Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism. Nature Biotechnology. 43(4). 534–538. 8 indexed citations

Cosentino, Andrea, Adele Mucci, Jing Zeng, et al.. (2023). 237 Epitope engineered hematopoietic stem cells to enable multi-specificity CAR-T cells for acute myeloid leukemia. SHILAP Revista de lepidopterología. A273–A273. 1 indexed citations

Fox, Thomas A., Lina Petersone, Erin Waters, et al.. (2022). Therapeutic gene editing of T cells to correct CTLA-4 insufficiency. Science Translational Medicine. 14(668). eabn5811–eabn5811. 21 indexed citations

Crippa, Stefania, Anastasia Conti, Valentina Vavassori, et al.. (2022). Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. Molecular Therapy. 31(1). 230–248. 10 indexed citations

Ferrari, Samuele, Stefano Beretta, Aurélien Jacob, et al.. (2021). BAR-Seq clonal tracking of gene-edited cells. Nature Protocols. 16(6). 2991–3025. 9 indexed citations

Ferrari, Samuele, Valentina Vavassori, Daniele Canarutto, et al.. (2021). Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation. SHILAP Revista de lepidopterología. 3. 618378–618378. 30 indexed citations

10.

Ferrari, Samuele, Aurélien Jacob, Stefano Beretta, et al.. (2020). Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nature Biotechnology. 38(11). 1298–1308. 108 indexed citations

11.

Schiroli, Giulia, Anastasia Conti, Samuele Ferrari, et al.. (2019). Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response. Cell stem cell. 24(4). 551–565.e8. 203 indexed citations

12.

Petrillo, Carolina, Lucy Thorne, Giulia Unali, et al.. (2018). Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells. Cell stem cell. 23(6). 820–832.e9. 79 indexed citations

13.

Schiroli, Giulia, Samuele Ferrari, Anthony Conway, et al.. (2017). Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Science Translational Medicine. 9(411). 159 indexed citations

14.

Díez, Begoña, Pietro Genovese, Francisco J Roman‐Rodriguez, et al.. (2017). Therapeutic gene editing in CD 34 ⁺ hematopoietic progenitors from Fanconi anemia patients. EMBO Molecular Medicine. 9(11). 1574–1588. 44 indexed citations

15.

Giuliani, Erica, Claudia Piovan, Cinzia Scavullo, et al.. (2016). 130. Purification of Large Scale mRNA Encoding ZFN Nucleases by dHPLC Technology. Molecular Therapy. 24. S53–S54. 2 indexed citations

16.

Casucci, Monica, Benedetta Nicolis di Robilant, Laura Falcone, et al.. (2013). CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. Blood. 122(20). 3461–3472. 290 indexed citations

17.

Gabriel, Richard, Angelo Lombardo, Anne I.J. Arens, et al.. (2011). An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nature Biotechnology. 29(9). 816–823. 403 indexed citations

18.

Mátrai, Janka, Alessio Cantore, Cynthia C. Bartholomae, et al.. (2011). Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology. 53(5). 1696–1707. 111 indexed citations

19.

Genovese, Pietro, Elena Provasi, Zulma Magnani, et al.. (2010). Abstract 2937: Editing central memory T lymphocyte specificity for safe and effective adoptive immunotherapy of leukemia. Cancer Research. 70(8_Supplement). 2937–2937. 1 indexed citations

20.

Lombardo, Angelo, Pietro Genovese, Christian Beauséjour, et al.. (2007). Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nature Biotechnology. 25(11). 1298–1306. 647 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact